ACAD
37.509
+0.519
+1.403%
AEMD
0.975
+0.005
+0.4639%
APRI
1.908
+0.118
+6.6145%
ARNA
27.58
+0.73
+2.72%
ATEC
3.87
+0.1
+2.65%
CNAT
5.11
+0.01
+0.20%
CRXM
0.137
-0.018
-11.71613%
CYTX
0.47
0.00
+0.06%
DXCM
44.09
-0.9
-2.00%
GNMK
8.07
-0.04
-0.49%
HALO
17.84
+0.1
+0.56%
ILMN
206.827
+0.347
+0.1679%
INNV
0.087
+0.001
+0.578%
INO
6.35
+0.11
+1.76%
ISCO
1.55
-0.12
-7.19%
ISIS
57.56
0.00
0.00%
LGND
142.315
+0.165
+0.116%
LPTN
2.93
-2.93
-100.00%
MBVX
0.73
0.00
-0.03%
MEIP
2.39
+0.06
+2.58%
MNOV
6.54
-0.08
-1.21%
MRTX
14.1
-0.15
-1.05%
MSTX
0.13
-0.01
0.00%
NBIX
60.25
-0.62
-1.02%
NUVA
53.805
+0.095
+0.177%
ONCS
1.2
-0.01
-0.8512%
ONVO
1.49
-0.03
-1.97%
OREX
1.94
+0.05
+2.65%
OTIC
3.425
-0.05
-1.439%
QDEL
41.49
+0.13
+0.31%
RCPT
231.96
0.00
0.00%
RGLS
1.3
-0.02
-1.52%
RMD
78.66
+0.24
+0.31%
SCIE
0
0.00
0.00%
SPHS
2.278
-0.002
-0.0790%
SRNE
2.9
+0.05
+1.75%
TROV
0.909
+0.119
+15.1013%
VICL
2.431
-0.099
-3.913%
VOLC
18
0.00
0.00%
ZGNX
38.3
+0.2
+0.52%
ACAD
37.509
+0.519
+1.403%
AEMD
0.975
+0.005
+0.4639%
APRI
1.908
+0.118
+6.6145%
ARNA
27.58
+0.73
+2.72%
ATEC
3.87
+0.1
+2.65%
CNAT
5.11
+0.01
+0.20%
CRXM
0.137
-0.018
-11.71613%
CYTX
0.47
0.00
+0.06%
DXCM
44.09
-0.9
-2.00%
GNMK
8.07
-0.04
-0.49%
HALO
17.84
+0.1
+0.56%
ILMN
206.827
+0.347
+0.1679%
INNV
0.087
+0.001
+0.578%
INO
6.35
+0.11
+1.76%
ISCO
1.55
-0.12
-7.19%
ISIS
57.56
0.00
0.00%
LGND
142.315
+0.165
+0.116%
LPTN
2.93
-2.93
-100.00%
MBVX
0.73
0.00
-0.03%
MEIP
2.39
+0.06
+2.58%
MNOV
6.54
-0.08
-1.21%
MRTX
14.1
-0.15
-1.05%
MSTX
0.13
-0.01
0.00%
NBIX
60.25
-0.62
-1.02%
NUVA
53.805
+0.095
+0.177%
ONCS
1.2
-0.01
-0.8512%
ONVO
1.49
-0.03
-1.97%
OREX
1.94
+0.05
+2.65%
OTIC
3.425
-0.05
-1.439%
QDEL
41.49
+0.13
+0.31%
RCPT
231.96
0.00
0.00%
RGLS
1.3
-0.02
-1.52%
RMD
78.66
+0.24
+0.31%
SCIE
0
0.00
0.00%
SPHS
2.278
-0.002
-0.0790%
SRNE
2.9
+0.05
+1.75%
TROV
0.909
+0.119
+15.1013%
VICL
2.431
-0.099
-3.913%
VOLC
18
0.00
0.00%
ZGNX
38.3
+0.2
+0.52%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …